loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2011_055___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Noramco

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INTERMEDIATES

    INSPECTIONS & REGISTRATIONS

    OTHER PRODUCTS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NORAMCO, LLC. Wilmington US (1)

    filter

    01 Naloxone hydrochloride dihydrate (1)

    filter

    01 U.S.A (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    NORAMCO, LLC. Wilmington US

    Contact Supplier
    • FDA
    Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Naloxone hydrochloride dihydrate

    PDF Supplier PDF
    URL Supplier Web Content
    CEP 2011-055 - Rev 03
    Valid
    Chemical
    2023-09-06
    729
    Noramco

    CPhI North America

    Attending

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for CEP 2011-055 - Rev 03 of Noramco, Llc. Wilmington Us

    Looking for Certificates of Suitability (CEPs) for CEP 2011-055 - Rev 03 of Noramco, Llc. Wilmington Us 1

    20

    Noramco, Llc. Wilmington Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    They are recognized for Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

    One of their significant offerings is Naloxone hydrochloride dihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2011-055 - Rev 03

    This Chemical Type CEP, issued on September 06, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 729 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY